Publications
2023
- Accidents vasculaires cérébraux suivant l’administration d’un vaccin contre la COVID-19
- Zona survenu à la suite de la vaccination contre la COVID-19 au Québec
- Paralysie de Bell survenue à la suite de la vaccination contre la COVID-19 au Québec
- Manifestations cliniques indésirables à la suite de la vaccination de base contre la COVID-19 déclarées au système de surveillance passive du Québec
- Surveillance active de la sécurité des trois premières doses de vaccin contre la COVID-19 au Québec
- Administration of COVID-19 booster doses: Recommendations for winter and spring 2023
- Administration de doses de rappel du vaccin contre la COVID-19 : recommandations pour l’hiver et le printemps 2023
2022
- Administration d’une dose de vaccin bivalent aux personnes vaccinées avec le vaccin monovalent contre la COVID-19 depuis le 15 août 2022
- Vaccination contre l’influenza et la COVID-19 à l’automne 2022
- Stratégie vaccinale contre la COVID-19 à préconiser au Québec en 2022 et pertinence d’une 2e dose de rappel pour certains groupes vulnérables
- Administration des doses subséquentes d’un vaccin contre la COVID-19 chez les personnes ayant développé une péricardite ou une myocardite
- Enquête épidémiologique sur les travailleurs de la santé atteints par la COVID-19
- Vaccination contre l’hépatite virale A suite à une éclosion à Nunavik
Publications
2021
- SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study
- Characterization and evolution of infection control practices among SARS-CoV-2 infected healthcare workers of acute care hospitals and long-term care facilities in Quebec, Canada, Spring 2020
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- Infectivity of Healthcare Workers Diagnosed with SARS-CoV-2 Infection Approximately 2 weeks after Onset of Symptoms: a Cross-Sectional Study
2020
- Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada
- Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017
- Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada
- Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis
- Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
2019
- Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent
- Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada
- Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008-2009 Seasonal Influenza Vaccine Receipt
- A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine
- Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal
- Letter to the editor: Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections